MoonLake Immunotherapeutics (MLTX) Minority Interest (2022 - 2025)

MoonLake Immunotherapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at $2.3 million for Q3 2025.

• In Q3 2025, Minority Interest fell 68.73% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $2.3 million (down 68.73% YoY), while the FY2024 annual figure was $6.6 million, down 63.14% from the prior year.
• Minority Interest was $2.3 million for Q3 2025 at MoonLake Immunotherapeutics, down from $4.2 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $64.7 million in Q3 2023 to a low of $2.3 million in Q3 2025.
• Historically, Minority Interest has averaged $16.6 million across 4 years, with a median of $9.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Minority Interest surged 137.2% in 2023, then slumped 88.71% in 2024.
• A 4-year view of Minority Interest shows it stood at $19.9 million in 2022, then retreated by 10.33% to $17.8 million in 2023, then tumbled by 63.14% to $6.6 million in 2024, then sank by 65.2% to $2.3 million in 2025.
• The last three Minority Interest figures came in at $2.3 million (Q3 2025), $4.2 million (Q2 2025), and $5.1 million (Q1 2025), per Business Quant data.